Updated results of the COVID-19 in MS global data sharing initiative validate consistent associations of anti-CD20 and other reported risk factors with severe COVID-19 outcomes
Year: 2021
Type: article
Study design: Observational Study
Authors: Simpson-Yap, S., PIRMANI, Ashkan, DE BROUWER, Edward, GEYS, Lotte, PARCIAK, Tina, Helme, A., Rijke, N., Kalincik, T., Hillert, J., Moreau, Y., Edan, G., Spelman, T., McBurney, R., Schmidt, H., Bergmann, A., Braune, S., Stahmann, A., Salter, A., Bebo, B., van der Walt, A., Butzkueven, H., Rojas, J. I., van der Mei, I., Sciascia do Olival, G., Magyari, M., Alonso, R., Nicholas, R., Chertcoff, A., Zabalza, A., Arrambide, G., Sharmin, S., DESCAMPS, Anne-Marie, Costers, L., Dobson, R., Miller, A., Rodrigues, P., Comi, G., PEETERS, Liesbet
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3214537137